Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer
JACKMAN, David M, YEAP, Beow Y, FREIDLIN, Boris, OSTLER, Patricia A, LUCCA, Joan, LYNCH, Thomas J, JOHNSON, Bruce E, JDNNE, Pasi A, LINDEMAN, Neal I, FIDIAS, Panos, RABIN, Michael S, TEMEL, Jennifer, SKARIN, Arthur T, MEYERSON, Matthew, HOLMES, Alison J, BORRAS, Ana M
Published in Journal of clinical oncology (01.03.2007)
Published in Journal of clinical oncology (01.03.2007)
Get full text
Journal Article
Vaccination With Irradiated Autologous Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor Augments Antitumor Immunity in Some Patients With Metastatic Non–Small-Cell Lung Carcinoma
SALGIA, Ravi, LYNCH, Thomas, LUKANICH, Jean, BUENO, Raphael, WAIN, John, MATHISEN, Douglas, WRIGHT, Cameron, FIDIAS, Panos, DONAHUE, Dean, CLIFT, Shirley, HARDY, Steve, NEUBERG, Donna, SKARIN, Arthur, MULLIGAN, Richard, WEBB, Iain, SUGARBAKER, David, MIHM, Martin, DRANOFF, Glenn, LUCCA, Joan, LYNCH, Cathleen, JUNG, Ken, HODI, F. Stephen, JAKLITSCH, Michael, MENTZER, Steve, SWANSON, Scott
Published in Journal of clinical oncology (15.02.2003)
Published in Journal of clinical oncology (15.02.2003)
Get full text
Journal Article
A Phase II Trial of the Cyclin-dependent Kinase Inhibitor Flavopiridol in Patients with Previously Untreated Stage IV Non-Small Cell Lung Cancer
SHAPIRO, Geoffrey I, SUPKO, Jeffrey G, PATTERSON, Angus, LYNCH, Cathy, LUCCA, Joan, ZACAROLA, Patrick F, MUZIKANSKY, Alona, WRIGHT, John J, LYNCH, Thomas J, ROLLINS, Barrett J
Published in Clinical cancer research (01.06.2001)
Get full text
Published in Clinical cancer research (01.06.2001)
Journal Article
A Phase II Study of Weekly Paclitaxel in Elderly Patients with Advanced Non-Small Cell Lung Cancer
FIDIAS, Panos, SUPKO, Jeffrey G, SKARIN, Arthur, LYNCH, Thomas J, MARTINS, Renato, BORAL, Anthony, CAREY, Robert, GROSSBARD, Michael, SHAPIRO, Geoffrey, OSTLER, Patricia, LUCCA, Joan, JOHNSON, Bruce E
Published in Clinical cancer research (01.12.2001)
Get full text
Published in Clinical cancer research (01.12.2001)
Journal Article
A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer
Jackman, David M, Cioffredi, Leigh A, Jacobs, Lorraine, Sharmeen, Farhana, Morse, Linda K, Lucca, Joan, Plotkin, Scott R, Marcoux, Paul J, Rabin, Michael S, Lynch, Thomas J, Johnson, Bruce E, Kesari, Santosh
Published in Oncotarget (28.02.2015)
Published in Oncotarget (28.02.2015)
Get full text
Journal Article
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
Jackman, David M., Kindler, Hedy L., Yeap, Beow Y., Fidias, Panos, Salgia, Ravi, Lucca, Joan, Morse, Linda K., Ostler, Patricia A., Johnson, Bruce E., Jänne, Pasi A.
Published in Cancer (15.08.2008)
Published in Cancer (15.08.2008)
Get full text
Journal Article
Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study
Jänne, Pasi A., Gurubhagavatula, Sarada, Yeap, Beow Y., Lucca, Joan, Ostler, Patricia, Skarin, Arthur T., Fidias, Panos, Lynch, Thomas J., Johnson, Bruce E.
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2004)
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2004)
Get full text
Journal Article
A pilot study of direct care nurse (DCN) education to improve adherence and knowledge of erlotinib in patients with non-small cell lung cancer
Lucca, Joan Vern, Hooper, Catherine L., Boucher, Jean, Pedulla, Lillian Vitale, Berry, Donna Lynn, Marcoux, J Paul
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A phase II trial of erlotinib for EGFR mutant NSCLC to prospectively assess biopsy feasibility and acquired resistance at disease progression
Redig, Amanda J., Taibi, Myriam, Oxnard, Geoffrey R., Boucher, David, Rabin, Michael S., Marcoux, J Paul, Gandhi, Leena, Huberman, Mark, Rangachari, Deepa, Lucca, Joan Vern, Morse, Linda K., Andan, MaChristine, Johnson, Bruce E., Costa, Daniel Botelho, Janne, Pasi A., Jackman, David Michael
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Abstract A254: A phase 1 safety and pharmacokinetic (PK) study of PI3K/TORC1/TORC2 inhibitor, XL765 (SAR245409), in combination with erlotinib in patients (pts) with advanced solid tumors
Janne, Pasi A., Felip, Enriqueta, Cedrés, Susana, Cohen, Steven J., Engelman, Jeffrey A., Lucca, Joan, Martínez, Pablo, von Mehren, Margaret, Gendreau, Steven B., Lara, Katherine K., Martini, Jean-Francois, Cohen, Roger B.
Published in Molecular cancer therapeutics (10.12.2009)
Published in Molecular cancer therapeutics (10.12.2009)
Get full text
Journal Article
P3-096: Phase II study of erlotinib in chemo–naïve women with advanced pulmonary adenocarcinoma
Jackman, David M., Lindeman, Neal, Lucca, Joan, Morse, Linda K., Rabin, Michael S., Marcoux, J.P., Huberman, Mark S., Johnson, Bruce E., Janne, Pasi A.
Published in Journal of thoracic oncology (01.08.2007)
Published in Journal of thoracic oncology (01.08.2007)
Get full text
Journal Article
P1-132: Phase II study of erlotinib plus bevacizumab in patients with previously treated malignant pleural mesothelioma
Jackman, David M., Kindler, Hedy L., Fidias, Panagiotis, Salgia, Ravi, Lucca, Joan, Ostler, Patricia, Morse, Linda K., Lynch, Thomas J., Johnson, Bruce E., Janne, Pasi A.
Published in Journal of thoracic oncology (01.08.2007)
Published in Journal of thoracic oncology (01.08.2007)
Get full text
Journal Article
O-243 Clinical benefits in patients with advanced non-small-cell lung cancer treated with gefitinib (“Iressa”, ZD1839) in the compassionate use program
Janne, Pasi A., Gurubhagavatula, Sarada, Lucca, Joan, Ostler, Patricia, Skarin, Arthur T., Fidias, Panos, Lynch, Thomas J., Johnson, Bruce E.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)
Get full text
Journal Article
P-348 A phase I trial of gemcitabine followed by flavopiridol in patients with solid tumors
Goffin, John, Appleman, Leonard, Ryan, David, Fidias, Panos, Lucca, Joan, Regan, Eileen, Dimitrios Colevas, A., Eder, Joseph Paul, Supko, Jeffrey, Shapiro, Geoffrey
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)
Get full text
Journal Article
Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, then Surgery in Stage III Non-Small Cell Lung Cancer
Lori J. Wirth, Joan Lucca, Patricia Ostler, Panos Fidias, Cathy Lynch, Pasi A. Jänne, Roy S. Herbst, Bruce E. Johnson, David J. Sugarbaker, Douglas J. Mathisen, Jeanne M. Lukanich, Noah C. Choi, Stuart M. Berman, Arthur T. Skarin
Published in Clinical cancer research (01.05.2003)
Get full text
Published in Clinical cancer research (01.05.2003)
Journal Article